Literature DB >> 6195337

What has adjuvant chemotherapy of osteosarcoma achieved? Discussion paper.

R L Souhami.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6195337      PMCID: PMC1439653          DOI: 10.1177/014107688307601111

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   18.000


× No keyword cloud information.
  23 in total

1.  High-dose methotrexate in osteogenic sarcoma: a 5-year experience.

Authors:  N Jaffe; E Frei; H Watts; D Traggis
Journal:  Cancer Treat Rep       Date:  1978-02

2.  Is it ethical not to conduct a prospectively controlled trial of adjuvant chemotherapy in osteosarcoma?

Authors:  B Lange; A S Levine
Journal:  Cancer Treat Rep       Date:  1982-09

3.  Chemotherapy for osteogenic sarcoma: an investigative method, not a recipe.

Authors:  G Rosen; A Nirenberg
Journal:  Cancer Treat Rep       Date:  1982-09

4.  Methotrexate as adjuvant treatment for primary osteosarcoma.

Authors:  J H Edmonson; S J Green; J C Ivins; G S Gilchrist; E T Cregan; D J Pritchard; W A Smithson; D C Dahlin; W F Taylor
Journal:  N Engl J Med       Date:  1980-09-11       Impact factor: 91.245

5.  Treatment of osteogenic sarcoma. I. Effect of adjuvant high-dose methotrexate after amputation.

Authors:  S A Rosenburg; B A Chabner; R C Young; C A Seipp; A S Levine; J Costa; T A Hanson; G C Head; R M Simon
Journal:  Cancer Treat Rep       Date:  1979-05

6.  Improved three-year disease-free survival in osteogenic sarcoma.

Authors:  W A Bleyer; J E Haas; P Feigl; T K Greenlee; R T Schaller; A Morgan; T W Pendergrass; F L Johnson; I D Bernstein; R L Chard; J R Hartmann
Journal:  J Bone Joint Surg Br       Date:  1982

7.  cis-Dichlorodiammineplatinum (II) in advanced osteogenic sarcoma.

Authors:  J J Ochs; A I Freeman; H O Douglass; D S Higby; E R Mindell; L F Sinks
Journal:  Cancer Treat Rep       Date:  1978-02

8.  Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy.

Authors:  G Rosen; B Caparros; A G Huvos; C Kosloff; A Nirenberg; A Cacavio; R C Marcove; J M Lane; B Mehta; C Urban
Journal:  Cancer       Date:  1982-03-15       Impact factor: 6.860

9.  Primary osteogenic sarcoma: the rationale for preoperative chemotherapy and delayed surgery.

Authors:  G Rosen; R C Marcove; B Caparros; A Nirenberg; C Kosloff; A G Huvos
Journal:  Cancer       Date:  1979-06       Impact factor: 6.860

10.  Adjuvant adriamycin and cis-diamminedichloroplatinum (cis-platinum) in primary osteosarcoma.

Authors:  L J Ettinger; H O Douglass; D J Higby; E R Mindell; F Nime; J Ghoorah; A I Freeman
Journal:  Cancer       Date:  1981-01-15       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.